60 related articles for article (PubMed ID: 38653918)
1. Dry eye and decreased tear film stability in primary acquired nasolacrimal duct obstruction patients.
Yu X; Wang K; Hu Y; Meng Z; Li J; Liu Y; Xiao L; Chen M; Li S; Shen Y; Chen R; Liang X
Int Ophthalmol; 2024 Jun; 44(1):277. PubMed ID: 38916702
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of a New Active Tear Substitute Containing 0.2% Hyaluronic Acid and 0.001% Hydrocortisone on Signs and Symptoms of Dry Eye Disease by Means of Low- and High-Tech Assessments.
Fogagnolo P; Giannaccare G; Mencucci R; Villani E; Orfeo V; Aragona P;
Ophthalmol Ther; 2024 Jan; 13(1):251-266. PubMed ID: 37948015
[TBL] [Abstract][Full Text] [Related]
3. Randomized trial comparing the effects of a 3D head-up system and microscope eyepiece-assisted simulated vitrectomy with intraocular illumination on the ocular surface of an operator.
Ge X; Liu D; Fan F; Xu T; Zhang Z; Liu H; Li S
BMC Ophthalmol; 2024 Jun; 24(1):241. PubMed ID: 38853245
[TBL] [Abstract][Full Text] [Related]
4. Safe and Effective Management of Dry Eye Symptoms with Hydroxypropyl Guar and Hyaluronic Acid Dual-Polymer Lubricating Eye Drops: A Review of Preclinical and Clinical Studies.
Srinivasan S; Garofalo R; Williams R
Clin Ophthalmol; 2023; 17():3883-3898. PubMed ID: 38105908
[TBL] [Abstract][Full Text] [Related]
5. Tear film stability in patients with symptoms of dry eye after instillation of dual polymer hydroxypropyl guar/sodium hyaluronate vs single polymer sodium hyaluronate.
Kanclerz P; Bazylczyk N; Radomski SA
Int Ophthalmol; 2024 Apr; 44(1):193. PubMed ID: 38653918
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of tear meniscus by optical coherence tomography after different sodium hyaluronate eyedrops instillation.
Carracedo G; Pastrana C; Serramito M; Rodriguez-Pomar C
Acta Ophthalmol; 2019 Mar; 97(2):e162-e169. PubMed ID: 30280515
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the clinical effects of carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: a 4-week, prospective, open-label, randomized, parallel-group, noninferiority study.
Wang TJ; Wang IJ; Ho JD; Chou HC; Lin SY; Huang MC
Clin Ther; 2010 Jan; 32(1):44-52. PubMed ID: 20171410
[TBL] [Abstract][Full Text] [Related]
8. The effect of hydroxypropyl-guar nanoemulsion on signs and symptoms of dry eye.
Markoulli M; Wong K; Jia T; Siddireddy JS; Briggs N; Tan J
Cont Lens Anterior Eye; 2022 Dec; 45(6):101736. PubMed ID: 35835650
[TBL] [Abstract][Full Text] [Related]
9. [Sustained effects of sodium hyaluronate solution on tear film stability evaluated by Tear Stability Analysis System].
Yamaguchi M; Kutsuna M; Maruo H; Hara Y; Uno T; Kataoka H; Ohashi Y
Nippon Ganka Gakkai Zasshi; 2011 Feb; 115(2):134-41. PubMed ID: 21400919
[TBL] [Abstract][Full Text] [Related]
10. The effect of sodium hyaluronate on tear film stability in patients with dry eye syndrome after cataract surgery.
Chen N; Zhang JS; Zhang TX; Fan BL; Ning Y
Graefes Arch Clin Exp Ophthalmol; 2023 Apr; 261(4):1011-1017. PubMed ID: 36378338
[TBL] [Abstract][Full Text] [Related]
11. Artificial Tears: A Systematic Review.
Semp DA; Beeson D; Sheppard AL; Dutta D; Wolffsohn JS
Clin Optom (Auckl); 2023; 15():9-27. PubMed ID: 36647552
[TBL] [Abstract][Full Text] [Related]
12. Current trends in pharmaceutical treatment of dry eye disease: A review.
Mohamed HB; Abd El-Hamid BN; Fathalla D; Fouad EA
Eur J Pharm Sci; 2022 Aug; 175():106206. PubMed ID: 35568107
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Dry Eye and its Subtypes in an Elderly Population with Cataracts in Indonesia.
Noor NA; Rahayu T; Gondhowiardjo TD
Clin Ophthalmol; 2020; 14():2143-2150. PubMed ID: 32801623
[TBL] [Abstract][Full Text] [Related]
14. Modern approach to the treatment of dry eye, a complex multifactorial disease: a P.I.C.A.S.S.O. board review.
Aragona P; Giannaccare G; Mencucci R; Rubino P; Cantera E; Rolando M
Br J Ophthalmol; 2021 Apr; 105(4):446-453. PubMed ID: 32703782
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
